Crime & Justice
Judge Approves Bayer's $7.25 Billion Roundup Cancer Settlement
A St. Louis judge signs off on a two-decade payment plan for current and future Roundup cancer claims, months after the Supreme Court sided with Monsanto on warning labels.
By NATALIE SINCLAIRStaff Correspondent · MISSOURI · Nov 20, 7:24 PM · 2 min. read

Illustration · Liberty Bell Report
A Missouri judge on Friday gave final approval to Bayer's settlement of up to $7.25 billion over claims that its Roundup weed killer caused cancer, a ruling that could close the book on most of the litigation that has dogged the German company since it bought Monsanto.
St. Louis Circuit Judge Timothy Boyer approved the deal, first announced in February, in a written judgment, Reuters reported. The money will be paid out over roughly two decades to people who say Bayer should have warned them that Roundup could cause non-Hodgkin lymphoma, PBS News reported.
What the Deal Covers
The settlement is designed to reach both people already diagnosed and those who may be diagnosed in the future, according to Reuters. Bayer has faced roughly 65,000 claims, The Guardian reported. The company continues to deny that Roundup causes cancer.
Bayer chief executive Bill Anderson called the approval "a decisive milestone," Reuters reported. Bloomberg was among the first to report the approval on Friday.
Not everyone is satisfied. Deutsche Welle reported that some plaintiffs' lawyers argue the payments are too low for people living with cancer. The ruling can still be appealed, according to Reuters.
A Long Road to Friday
The litigation has been costly for the company and its owners. The Guardian reported that Bayer shares have lost about 46 percent of their value since the 2018 Monsanto purchase.
The legal ground shifted in June, when the U.S. Supreme Court ruled 7-2 in Monsanto v. Durnell that federal pesticide law preempts state claims faulting the company for not putting a cancer warning on Roundup's label. The case grew out of a Missouri jury's $1.25 million award to a man who said Roundup caused his cancer, NPR reported. The justices pointed to the Environmental Protection Agency's determination that the product's label does not require a cancer warning.
Why It Matters
For years, the fight over Roundup has played out in courtrooms one jury at a time, with very different results in different states. The Supreme Court's June decision told the country that the label rules are set in Washington, by the agency Congress put in charge, not rewritten case by case in fifty state courts.
Friday's approval adds something the courtroom fights never offered: a fixed payment schedule for people who are sick now and for those who may be diagnosed later. That certainty matters to families who have waited years for answers, and to farmers, who now have clearer rules about a product whose label the EPA approved.
What Comes Next
Objectors can still take the ruling to a higher court. Bayer will now move toward carrying out the payment plan over the coming years, while critics continue to press their case that the compensation falls short. We will follow any appeal as it develops.
Sources
- Bloomberg: Bayer's $7.25 Billion Roundup Settlement Approved by US Judge (link)
- PBS News: Court approves $7.25 billion Bayer settlement over claims Roundup weed killer caused cancer (link)
- The Guardian: Judge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer (link)
- Deutsche Welle: US judge approves Bayer's $7.25 billion cancer settlement (link)
- Reuters via Investing.com: Missouri judge approves Bayer's $7.25 billion Roundup settlement (link)
- NPR: Supreme Court backs Monsanto in its fight against liability from popular weed killer (link)
— 30 —


